AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Botulinum Toxin Type A on Motor Function in Children With Cerebral Palsy

RecruitingNAAges 8 Years - 17 YearsAllInstituto Teletón Chile
💬

In plain words

What the trial is, and whether it could suit you

Project Identification and Researchers Title: "Changes in functionality and quality of life when applying the botulinum toxin type A infiltration protocol in children and adolescents with cerebral palsy of the spastic hemiparesis type GMFCS I and II, from the Teletón Institute Santiago: A prospective single-group trial." This project is led by a group of physiatrists from the Teletón Institute, along with a team of co-investigators specialized in kinesiology, occupational therapy, and nursing. Study Relevance The study aims to generate scientific evidence on the effectiveness of the BoNT-A infiltration protocol in the functionality and quality of life of children with spastic hemiparesis. The results could optimize therapeutic interventions at the Teletón Institute, improve patient well-being, and expand the coverage of therapeutic services for spasticity. Problem Statement Cerebral p

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Spastic hemiparesis type Cerebral Palsy * Gross Motor Classification System I-II * Age 8 to 17 years (based on validation ages for scales to be used) * Minimum of 6 months since last botulinum toxin injection * Informed consent signed by legal guardian and assent from users aged 12 to 17 years Exclusion Criteria: * Cognitive impairment that prevents following instructions for functional assessments * Limitation of joint range not caused by spasticity * Patients diagnosed with other diseases causing spasticity, different from cerebral palsy * Patients with other neuromuscular diseases
💊

What it tests

  • Botulinum toxin infiltration
📍

Where

1 site
Instituto Teleton Santiago
Santiago, Chile
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy